1Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea
2Department of Internal Medicine, H+ Yangji Hospital, Seoul, Korea
Copyright © 2023 Korean Society of Gastrointestinal Endoscopy
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Conflicts of Interest
The authors have no potential conflicts of interest.
Funding
None.
Author Contributions
Conceptualization: KBB; Data curation: SHR; Supervision: KBB; Writing–original draft: SHR; Writing–review & editing: KBB.
Study | Surgery (n) | Source of bleeding | Incidence (%) | Risk factors of bleeding | Treatment (%) |
---|---|---|---|---|---|
Tanizawa et al. (2010)25 | Gastrectomy (1,400) | Gastroduodenostomy, gastrojejunostomy, staple line of stomach, esophagojejunostomy | 0.43 | Lymph node dissection (≤D1) | Endoscopy (83), surgery (17) |
Jeong et al. (2011)24 | Gastrectomy (1,027) | Anastomosis, pseudoaneurysm | 1.6 | Operating time ≥3 hr, BMI ≥26 kg/m2 | Endoscopy (12), surgery (19), conservative (69) |
Kim et al. (2012)8 | Gastrectomy (2,031) | Gastrojejunostomy, gastroduodenostomy, esophagojejunostomy | 0.3 | Billroth II anastomosis, manual-anastomosis | Endoscopy (85), conservative (14) |
Park et al. (2014)20 | Gastrectomy (5,739) | Anastomosis | 0.8 | Male, comorbidity, previous abdominal surgery, palliative surgery | Endoscopy (28), surgery (28), conservative (44) |
Lee et al. (2017)23 | Gastrectomy (16,591) | Anastomosis | 0.22 | Subtotal gastrectomy | Endoscopy (69), surgery (17), conservative (14) |
Fernández-Esparrach et al. (2008)18 | RYGB (381) | Anastomosis | 5.8 | Endoscopy (27), conservative (73) | |
Jamil et al. (2008)9 | RYGB (933) | Gastrojejunostomy | 3.2 | Endoscopy (80), conservative (20) | |
Rabl et al. (2011)16 | RYGB (742) | Gastrojejunostomy, gastric remnant staple line | 3.5 | Diabetes mellitus | Endoscopy (75) |
Golda et al. (2013)21 | Right colectomy (350) | Anastomosis | 4.9 | Endoscopy (18) | |
Fernández de Sevilla Gómez et al. (2014)10 | Colectomy, ileal resection (2,069) | Anastomosis | 3.17 | Endoscopy (5), surgery (14), angiography (14), conservative (61) | |
Lou et al. (2014)19 | Anterior resection (2,181) | Anastomosis | 0.3 | Endoscopy (100) | |
Besson et al. (2016)22 | Left colectomy (729) | Anastomosis | 6.4 | Stapled anastomosis, diverticular disease | Endoscopy (79) |
Yekebas et al. (2007)26 | Pancreaticoduodenectomy (1,669) | Gastrojejunostomy, enteroenteric anastomosis | 2.2 | Pancreatic fistula | Endoscopy (42) |
Feng et al. (2014)11 | Pancreaticoduodenectomy (840) | Gastrojejunostomy, marginal ulcer, cholangiojejunostomy, pancreaticojejunostomy | 3.3 | Male, end-to-side-pancreaticojejunostomy, small pancreatic duct | Endoscopy (60) |
Gao et al. (2021)17 | Biliary-pancreatic surgery (37,772) | Gastric stump, anastomosis, Dieulafoy lesion | 0.069 | Endoscopy (100) |
Study | Type of surgery | Time to bleeding | Endoscopic management (%) | Success (%) | Risk factor of failure | Adverse events |
---|---|---|---|---|---|---|
Tanizawa et al. (2010)25 | Gastrectomy | 4.8 hr | Hemoclip (100) | 100 | Abscess | |
Kim et al. (2012)8 | Gastrectomy | 2.9 (1–4) day | Hemoclip (14), epinephrine injection (71) | 100 | ||
Lee et al. (2017)23 | Gastrectomy | 45 (21.5-126) hr | Hemoclip (52), epinephrine injection (32), fibrin glue injection (24), coagrasper (4), combination (24) | 64 | Large amount of blood, noncooperation, posterior wall side location | No |
Fernández-Esparrach et al. (2008)18 | RYGB | 6 (6–10.5) hr | Epinephrine (17), epinephrine plus polidocanol (83) | 100 | No | |
Jamil et al. (2008)9 | RYGB | 6.5 (0–43) hr | Epinephrine (11), heater probe (15), epinephrine+heater probe (52), hemoclip (7) | 78 | Aspiration, perforation | |
Rabl et al. (2011)16 | RYGB | Early (≤24 hr), 73.7%; late (2–14 day), 26.3% | Epinephrine injection (60), clipping (40) | 100 | Bypassed gastric remnant | No |
Golda et al. (2013)21 | Right colectomy | 6.5 (2.8–9.3) day | Epinephrine injection (33), epinephrine/etoxysclerol (67) | 33 | Blood and fecal contamination | Ileus |
Lou et al. (2014)19 | Anterior resection | 1 (1–3.3) day | Electrocoagulation (50), hemoclip (50) | 100 | No | |
Besson et al. (2016)22 | Left colectomy | 2 day | Hemoclip (27), sclerosis (30), hemoclip+sclerosis (19) | 100 | No | |
Martínez-Serrano et al. (2009)42 | Colorectal resection | 6.5 hr (0.5 hr–9 day) | Anastomosis washout (100) | 85.7 | No | |
Yekebas et al. (2007)26 | Pancreaticoduodenectomy | 4 (2–8) day | 20 | Beyond endoscopic accessibility, late bleeding | ||
Chen et al. (2015)12 | Pancreaticoduodenectomy | 5 (5–22) day | 57.1 | |||
Gao et al. (2021)17 | Biliary-pancreatic surgery | 8.1±5.7 day | Clipping (73), sclerosing agent injection (4), epinephrine injection (12), sclerosing plus clipping (8), epinephrine plus clipping (4) | 73.1 | Bleeding to endoscopy time (>12 hr) | No |
Study | Surgery (n) | Source of bleeding | Incidence (%) | Risk factors of bleeding | Treatment (%) |
---|---|---|---|---|---|
Tanizawa et al. (2010)25 | Gastrectomy (1,400) | Gastroduodenostomy, gastrojejunostomy, staple line of stomach, esophagojejunostomy | 0.43 | Lymph node dissection (≤D1) | Endoscopy (83), surgery (17) |
Jeong et al. (2011)24 | Gastrectomy (1,027) | Anastomosis, pseudoaneurysm | 1.6 | Operating time ≥3 hr, BMI ≥26 kg/m2 | Endoscopy (12), surgery (19), conservative (69) |
Kim et al. (2012)8 | Gastrectomy (2,031) | Gastrojejunostomy, gastroduodenostomy, esophagojejunostomy | 0.3 | Billroth II anastomosis, manual-anastomosis | Endoscopy (85), conservative (14) |
Park et al. (2014)20 | Gastrectomy (5,739) | Anastomosis | 0.8 | Male, comorbidity, previous abdominal surgery, palliative surgery | Endoscopy (28), surgery (28), conservative (44) |
Lee et al. (2017)23 | Gastrectomy (16,591) | Anastomosis | 0.22 | Subtotal gastrectomy | Endoscopy (69), surgery (17), conservative (14) |
Fernández-Esparrach et al. (2008)18 | RYGB (381) | Anastomosis | 5.8 | Endoscopy (27), conservative (73) | |
Jamil et al. (2008)9 | RYGB (933) | Gastrojejunostomy | 3.2 | Endoscopy (80), conservative (20) | |
Rabl et al. (2011)16 | RYGB (742) | Gastrojejunostomy, gastric remnant staple line | 3.5 | Diabetes mellitus | Endoscopy (75) |
Golda et al. (2013)21 | Right colectomy (350) | Anastomosis | 4.9 | Endoscopy (18) | |
Fernández de Sevilla Gómez et al. (2014)10 | Colectomy, ileal resection (2,069) | Anastomosis | 3.17 | Endoscopy (5), surgery (14), angiography (14), conservative (61) | |
Lou et al. (2014)19 | Anterior resection (2,181) | Anastomosis | 0.3 | Endoscopy (100) | |
Besson et al. (2016)22 | Left colectomy (729) | Anastomosis | 6.4 | Stapled anastomosis, diverticular disease | Endoscopy (79) |
Yekebas et al. (2007)26 | Pancreaticoduodenectomy (1,669) | Gastrojejunostomy, enteroenteric anastomosis | 2.2 | Pancreatic fistula | Endoscopy (42) |
Feng et al. (2014)11 | Pancreaticoduodenectomy (840) | Gastrojejunostomy, marginal ulcer, cholangiojejunostomy, pancreaticojejunostomy | 3.3 | Male, end-to-side-pancreaticojejunostomy, small pancreatic duct | Endoscopy (60) |
Gao et al. (2021)17 | Biliary-pancreatic surgery (37,772) | Gastric stump, anastomosis, Dieulafoy lesion | 0.069 | Endoscopy (100) |
Study | Type of surgery | Time to bleeding | Endoscopic management (%) | Success (%) | Risk factor of failure | Adverse events |
---|---|---|---|---|---|---|
Tanizawa et al. (2010)25 | Gastrectomy | 4.8 hr | Hemoclip (100) | 100 | Abscess | |
Kim et al. (2012)8 | Gastrectomy | 2.9 (1–4) day | Hemoclip (14), epinephrine injection (71) | 100 | ||
Lee et al. (2017)23 | Gastrectomy | 45 (21.5-126) hr | Hemoclip (52), epinephrine injection (32), fibrin glue injection (24), coagrasper (4), combination (24) | 64 | Large amount of blood, noncooperation, posterior wall side location | No |
Fernández-Esparrach et al. (2008)18 | RYGB | 6 (6–10.5) hr | Epinephrine (17), epinephrine plus polidocanol (83) | 100 | No | |
Jamil et al. (2008)9 | RYGB | 6.5 (0–43) hr | Epinephrine (11), heater probe (15), epinephrine+heater probe (52), hemoclip (7) | 78 | Aspiration, perforation | |
Rabl et al. (2011)16 | RYGB | Early (≤24 hr), 73.7%; late (2–14 day), 26.3% | Epinephrine injection (60), clipping (40) | 100 | Bypassed gastric remnant | No |
Golda et al. (2013)21 | Right colectomy | 6.5 (2.8–9.3) day | Epinephrine injection (33), epinephrine/etoxysclerol (67) | 33 | Blood and fecal contamination | Ileus |
Lou et al. (2014)19 | Anterior resection | 1 (1–3.3) day | Electrocoagulation (50), hemoclip (50) | 100 | No | |
Besson et al. (2016)22 | Left colectomy | 2 day | Hemoclip (27), sclerosis (30), hemoclip+sclerosis (19) | 100 | No | |
Martínez-Serrano et al. (2009)42 | Colorectal resection | 6.5 hr (0.5 hr–9 day) | Anastomosis washout (100) | 85.7 | No | |
Yekebas et al. (2007)26 | Pancreaticoduodenectomy | 4 (2–8) day | 20 | Beyond endoscopic accessibility, late bleeding | ||
Chen et al. (2015)12 | Pancreaticoduodenectomy | 5 (5–22) day | 57.1 | |||
Gao et al. (2021)17 | Biliary-pancreatic surgery | 8.1±5.7 day | Clipping (73), sclerosing agent injection (4), epinephrine injection (12), sclerosing plus clipping (8), epinephrine plus clipping (4) | 73.1 | Bleeding to endoscopy time (>12 hr) | No |
BMI, body mass index; RYGB, Roux-en-Y gastric bypass.
Values are presented as median (interquartile range), median (range), or mean±standard deviation. RYGB, Roux-en-Y gastric bypass.